Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis China (Exact Annual Revenue) by Year
China (Exact Annual Revenue) ($M)
Novartis China (Exact Annual Revenue): $4,188M in FY2025, up 7.7% from a year earlier.
Latest, FY2025
4,188
Period ended Dec 31, 2025
Change on a year earlier
+7.7%
3,890 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | China (Exact Annual Revenue) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,188 | +7.7% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 3,890 | +19.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 3,267 | +10.8% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 2,948 | +3.5% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 2,849 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up china (Exact Annual Revenue)
Cite this data
StockData. (2026). Novartis China (Exact Annual Revenue) ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-country-china-annual
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.